# Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

> **NCT07202494** · — · RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 700 (estimated)

## Conditions studied

- Multiple Sclerosis
- Neuromyelitis Optica Spectrum Disorders
- Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
- Alzheimer Disease
- Parkinson Disease
- Amyotrophic Lateral Sclerosis (ALS)
- Temporal Lobe Epilepsy
- Epilepsy
- Mild Traumatic Brain Injury
- Healthy Aging

## Interventions

- **OTHER:** Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging)

## Key facts

- **NCT ID:** NCT07202494
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-19
- **Primary completion:** 2030-05-18
- **Final completion:** 2030-05-18
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07202494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07202494, "Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07202494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*